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the presence ofLeishmania DNA. As positive controls the following isolates
were used: L. major, I. Infantum, L. tropics and L. braziliensis.
Conclusions: In endemic areas, clinical symptoms are suggestive of leish-
maniasis. However, in travelers who develop symptoms months after
leaving the endemic areas, the diagnosis is more difficult. PCR has proven
to be a rapid, sensitive and specific method for the detection of Leishmanis
DNA. Use of PCR techniques on archival specimens may be the only
method available to confirm a clinical diagnosis.
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ITuP278! candida ID, a new chromogenic medium compared
to Albicans ID2
A. M. Freydiere, F. Parant, C. Chaux, Y. Gille
Antiquaille, Hospices Civils de Lyon, 69321 Lyon cedex 5, France
ObJectives: While Albicans 102 (bioMerieux) detects only hexosaminidase
enzymatic activity for the identification of Candida albicans (blue colonies),
Candida 10 agar medium (bioMerieux) detects a second enzymatic activity
(patent pending) for the discrimination of different yeast species (pink
colonies). This study comparatively accesses the performance of Candida
ID and Albicans 102 agar media for the identification ofCandida albicans as
well as yeast isolation and discrimination.
Method: 139 yeast stock strains belonging to 16 species and 131 miscella-
neous clinical specimens, were streaked identically on both media. Growth
and aspect ofcolonies were monitored after 24, 48, and 72 hrs ofincubation
at 30°C. All isolates were identified using conventional mycological meth-
ods including the Bichrolatex albicans test and the ID32C system.
Results: In term ofyeast growth, Candida 10 and Albicans 102 agar media
showed similar performance. The second substrate included in the Candida
ID agar did not allow the identification of any additional Candida species
since 39 of 43 C. tropicalis, 5 of 5 C. kefyr, 2 of 5 C. sphaerica, 2 of 2 C.
lusitaniae, 1 of2 Saccharomyces cerevisiae and 1 of I C. utilis strains tested
yielded pink colonies.
However 5 stock C. tropicalis strains showing positive hexosaminidase
activity on Albicans 102 after 48 hrs ofincubation, yielded pink colonies on
Candida ID. These 5 false-C. albicans blue colonies on Albicans ID2 were
thus clearly distinguished from true C. albicans strains on Candida 10.
Moreover in 3 out of the 22 clinical samples yielding several yeast strains,
an additional Candida strain (I C. tropicalis, I C. kefyr and I C. parapsilosis
strain) was detected on Candida 10 due to the pink-eolored colonies.
Conclusion: Compared to Albicans 102, Candida 10 improved specificity
for C. albicans identification and differentiation ofcolonies in mixed fungal
populations.
ITuP279I Value of antigen detection in diagnosis and follow-
up of invasive aspergillosis
A. Sulahianl , F. Boutboull , P. Ribaud2, T. Leblanc3, C. Lacroix l , F.
Derouinl
lparasitology; 2JHematoiogy units, Paris, France
Objectives: To evaluate over a 4 year period the value of an ELISA
technique for the research of galactomannan (GM) for the diagnosis and
follow-up of invasive aspergillosis (lA).
Methods: The study evaluated the specificity and sensitivity ofthe detection
ofGM in 6209 sera from 797 hematology patients. Serial screening ofGM
was performed using a double sandwich ELISA assay (Platelia Aspergillus
Sanofi Diagnostics Pasteur). Fifty-three patients presented confirmed or
probable IA.
Results: Antigen was detected on at least two sequential sera in 48/53
patients, giving a sensitivity of 90.6%. GM antigenemia was detected
before the onset of radiological signs in 31/48 (64.6%) of patients with a
mean of -8.4 days, and before clinical symptoms in 18/48 (39.6%) patients
with a mean of -6.9 days. In patients without lA, 44/744 had positive
antigenemia resulting in a specificity of94%. False positive results could not
be related to the presence of concurrent mucositis.
Conclusions: This large prospective study allowed us to better define the
conditions ofuse ofGM immunocapture ELISA for the survey ofpatients at
high risk for IA confirming its excellent sensitivity for establishing the
diagnosis. The presence ofantigen has a good diagnostic value mainly when
there is an increase of the titer on two consecutive samples. A repeated
negative result is a strong argument against the diagnosis of IA but one
should be aware of the possibility of unexplained false negative results
occurring in less than 10% of cases.
ITuP280I Rapid identification of candida almeans by Bichro-
Latex A1bicans® Fumouze
S. Costa-de-Oliveira, A. Rodrigues, C. Pina Vaz, A. Freitas da Fonseca
Dept. Microbiology, Porto School ofMedicine, Porto, Portugal
Candidosis is increasing as a complication in both immunocompromised and
immunocompetent individuals, with a changing spectrum of emerging
Candida species. Thus, there is an obvious need for rapid and cost-efective--
ness differentiation of C. albicatls from other Candida species. The lenghty
incubation required for biochemical characterization of yeasts generally
hinders the clinical importance of yeast speciation.
Objectives: To evaluate Bichro-Latex Albicans® (BA) (Fumouze Diagnos-
tics, Asnieres, France) in comparison with germ tube test (GT) and with API
32C (Biomerieux, Vercieux, France).
Methods: A total of165 Candida clinical isolates, corresponding to 32 strains
ofC. albicans, the remaining being non-albicans strains were evaluated by GT
in bovine serum (Sigma), by two independent observers. In parallel, the
colonies from cultures were tested with BA, according to manufacturer's
instructions. Results obtained with GT and BA tests were compared with
biochemical characterization by API 32C.
Results: A false-negative reaction was considered with GT, resulting from
discrepancy between the two readings. GT had a 96.8% sensitivity and
100% specificity, with positive and negative predictive values of 100 and
99.3%, respectively. Sensitivity, specificity, positive and negative predictive
values for BA were of 100%, respectively.
Conclusions: Although boths tests showed a positive predictive value of
100%, GT takes 2 to 3 hours incubation plus time-eonsurning microscopy,
coupled with the hazards of handling pooled serum. Bichro-Latex Albi-
cans® Fumouze provides a fast easy-to-use and to interpret method to
identify C. albicans colonies directly from cultures.
ITuP282[ Using PCR to diagnose Pneumocystis earin;;
pneumonia in a South African dinicallaboratory
L. Dini, J. Frean
Department ofClinical Microbiology and Infectious Diseases, South African
Inslitutefor Medical Research,Johannesburg, South Africa
Pneumocystis carinii' causes a life-threatening pneumonia in im.munocompro-
rnised patients. In South Africa very few bronchoscopically-obtained
respiratory specimens are submitted for diagnosis. A sensitive diagnostic
technique for sputum specimens should improve clinical outcome.
Objectives: To assess a PCR technique to diagnose Pneumocystis carinii
pneumonia (PCP) in a clinical laboratory that receives mainly sputum
specimens.
Methods: 149 respiratory specimens, mainly sputa, were tested for P. carinii
by a direct immunofluorescent antibody stain and a PCR technique. A
single-tube nested PCR technique was used with primers that were
previously described by Mathis et al. (1997). A human primer pair, specific
for part of the human tyrosinase gene, was included in a separate tube to act
as an internal control for PCR inhibition.
Results: The nested PCR product was 265 base pairs (bp) long and the
human product was 420-bp. The IFA and PCR methods were not
significantly different by the McNemar's (paired chi-square) test (p =
0.054). The nested PCR technique was found to have a sensitivity of
63.5% and a specificity of91.8% (n = 149), in comparison with the IFA
assay. The positive predictive value was 80.5% and the negative predictive
value was 82.4%.
Conclusions: PCR is inherently more sensitive than IFA staining. However,
the PCR, as applied in this study, was less sensitive than expected, probably
due to the presence of inhibitors in the specimens. This will have to be
addressed before the test can be applied in a routine laboratory.
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Objetive: To evaluate the new Vitek2 ID-YST system for the identification
of yeast.
Methods: We study 163 yeasts strains (43 C. parapsilosis, 31 C. albicans, 20 C.
tropicalis, 19 C. glabrata, 19 C. krusei, 10 C. lusitaniae, 6 C. Jamata, 4 C.
guil/iermondii, 2 C. ktJyr, 2 Rhodotorula spp., 3 Trichosporon spp., 2 Sacchar-
omyces cerevisiae, 1 e. zeylanoides, 1 C. inconspicua and 1 Cryptococcus neoJor.
mans) isolated from clinical specimens. The API 20 C system (bioMerieux,
Spain) was considered the reference standard for the purposes of this study.
The~ strains were tested by the Vitek2 ID-YST system (bioMerieux. Spain)
according to the manufacturer's recomendations. Discrepancies between
both methods were repeated by both systems.
Results: The Vitek21D-YST system identified correctly 147 (90%) yeasts
strains at 18 hours. The most common Candida species and e. neoJormans were
identified correctly. C. zeylanoides y 1 T. cutaneum isolates were not
identified. Founcen isolates were misidentified: 5 C. Jamata as C. tropicalis
and one as R. glutinis, 1 C. kifyr as C. sphaerica, 1 C.lerusei as G. capitatum, I
C. parapsilosis as e. intennedia, 1 e. inconspicua as C. capitatum. Trirhosporon
and Rhodotorula misidentified specie level.
Condusions: The new Vitck2 ID-YST system was a good and alternative
method to identification of Candida spp. and other yeasts. although another
identification tests could be used to some uncommon yeasts.
ITuP284IIdentification of C. dubliniensis from dinical
specimens by Vitek2
A. Valverde. S. Bernal, M. Chavez. G. Quindos l , E. Martin
Microbiology S., Valme U.H., Seville; 'D. Microbiology, Euskadi Univ.,
Bilbao, Spain
Objetive: To evaluate the Vitek2 10-YST system for identification of the
new emergent yeast Candida dubliniensis from clinical specimens.
Methods: A total of 34 e. dubliniensis strains from clinical isolates were
tested by Vitek2 ID-YST system (bioMerieux, Spain) according to the
manufacturer's recomendation. All strains were previously identificated by
an indirect inmunofluorescence test with an anti-e. dubliniensis serum (J Clin
Microbioll998; 36:2428-2433) was considered the reference standard for the
purpose ofthis study. Although other additional tests were use as: germ tube.
morphology agars, do not growth or poor growth at 42°C and biochemical
tests. Discrepances identification between both methods were evaluated by
repeat testing.
Results: The Vitek2 ID-YST system identified correctly 31 (94%) e.
dubliniensis strains. Three strains were misidentified as C. albicans.
Condusions: The Vitek2 ID-YST system could be a good. easy and rapid
alternative to identify the e. dubliniensis isolates. without additional tests.
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ITuP28S1 Preliminary evaluation of LCx HIV RNA quantitative
assay
E. Tanzi, A. Amendola, D. Colzani. R. Pulvirenti l , C. Galli l , A. R.
Zanetti
Institute of Virology, University ojMilan; 'Scientific Affairs, Abbott
Diagnostics Division, Rome, Italy
Objectives: to evaluate the performance characteristics ofa new assay for the
quantitative detection ofHIV-RNA (Abbott LCx HIV RNA Quantitative)
in comparison with another target amplification method (Organon Nucli-
Sens) on samples from well characterized HIV-l positives.
Methods: we studied 60 patients, ofwhom 22 enrolled in a clinical trial for
combination therapy and 38 were vaccinated against influenza in the winter
of 1998-'99. NudiSens testing had been performed on fresh plasma, while
LCx was used retrospective lyon frozen samples (145 from the former and
143 from the latter group). The LCx method is based on RNA extraction by
QIAAmp followed by a competitive R T-PCR. Results are read by MEIA
technology on the automated LCx instrument; the ratio of the fluorescence
signal of the internal standard with the one of the target sequence amplifica-
tion is compared with a stored 6-points external curve. The sensitivity is 178
RNA copies/mL with 0.2 mL ofplasma (employed in the study) and reaches
50 copies/mL with 1 mL of sample. with a 5-log dynamic range.
Results: the precision on assay controls replicates ranged from 2.6% to
6.2%. On treated patients the sensitivity of the 2 assays was similar
(qualitative agreement: 90.3%). LCx showed a tendency to give higher
values. A significant difference (> 1 log) was recorded in 12 samples (8.3%)
and in 11 patients (50%) at least one result was different. but the trends of
HIV-RNA variations over time were identical or very similar in all cases.
On vaccinated subjects. tested to verify the effects of the flu vaccine on HIV
replication. many samples were NucliSens + /LCx - and a variation (0.5 log
or more) in RNA values was noted in 31.6% of patients by Nuclisens vs.
18.4% by LCx (p = n.s.).
COndusions: the LCx assay showed a very good precision. was easy to use
and showed a good sensitivity. From our experience it appeared well suited
for the monitoring of HIV-1 viral load in treated as well as in untreated
patients.
[TuP286! Comparison of quantitative measured of hepatitis
Cvirus RNA in fresh and one freeze-thaw serum samples
R. Mistik. M. Sinirtas. B. Ener
Uludag University, School ojMedicine Department ojClinical Microbiology
and Infectious Diseases Bursa, Turkey
Objectives: Quantification ofhepatitis C virus (HCV) RNA is valuable pan
of the clinician's armamentarium for managing patients with hepatitis C.
For this purpose, Quantiplex HCV-RNA Assay (Chiron Coop. USA) that
determines quantitative levels by branched DNA (bDNA) technology.
According to the test procedure, the results are affected by freezing-thawing
cycles and also by storing conditions but it is reponed that this effect i>
minimal after several cycles.
Methods: Blood samples were collected from 18 patients whom are known
to be positive for HCV-RNA. All samples were tested freshly by Quanti-
plex Assay (HCV-RNA 2.0 Assay, Chiron Coop.). Then ten samples were
stored at -18°C and eight samples were stored at -74°C for one month.
After one month all ofthem were thawed and tested by the same Quantiplex
assay. The quantitative values of HCV-RNA in fresh serums were the
baseline values and decreased or increased measurements obtained in the
stored samples were compared by these baseline values.
Results: As a results; 9% increasment for the value in stored samples at
-74°C (95% CI, SE: 0.086. p > 0.05). and 27% decreasment for the value in
stored sample at 18°C (95%, CI. SE: 0.051. p < 0.001).
CondusloM: In this repon. it is found that the quantification levels ofHCV-
RNA was affected by freezing-thawing and also degree ofthe temperature.
So for the usefullness ofQuantipiex assay, and reliable results for clinicians all
the samples should be measured at the same manner and ifsamples are stored
it should be preferred in stored at -74°C..
!TuP287I Comparison of the Cobas Amplicor HBV Monitor Test
and the Amplicor HBV Monitor Test
I.). MarinI, M. Poljakl , K. Semel,). Volkar-Meglic2, M. MatiCic2, V.
Brinovec2
'Inst. ojMicrobiol.; 2InJect. Dis. Depart., Clinical Center, Ljubljana, Slovenia
Objectives: The present study compared the performance oftwo versions of
the Amplicor HBV Monitor Test (Roche Molecular Systems, Branchburg,
NJ) for quantification ofhepatitis B virus (HBV) DNA in serum samples: the
new automated Cobas Amplicor HBV Monitor Test and the manual
microwell plate-based Amplicor HBV Monitor Test.
Material and Methods: 208 serum samples from the same number of
randomly selected. hepatitis B surface antigen positive patients from
Slovenia were tested using both test versions.
Results: Quantification of HBV DNA by the Cobas Amplicor HBV
Monitor Test and the Amplicor HBV Monitor test revealed no significant
difference in sensititviry between the two assays. 183 samples tested positive
and 20 negative by both test versions. Discordant results were obtained in 5
samples (3 samples tested positive by automated version only and 2 samples
tested positive by manual version only). HBV DNA concentrations deter-
mined by two test versions were highly correlated (N = 183, r = 0.97, P <
0.00(1) and were in good agreement (mean difference in 10gtO copies/ml ±
1.% standard deviations = 0.387 ± 1.139).
COndusion: The results of the study indicate that the new automated Cobas
Amplicor HBV Monitor Test could replace the microwell plate version of
the Amplicor HBV Monitor Test. The major inconvenience of the Cobas
Amplicor HBV Monitor Test is the required performance ofserial dilutions
of serum samples with high HBV DNA concentrations in order to extend
the narrow linear range of the assay.
